| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/25/2000 | WO2000029845A1 Apparatus and method for measuring the characteristics of an oilfield fluid or the like |
| 05/25/2000 | WO2000029831A1 Labeling microparticles capable of absorbing infrared light and methods of making and using the same |
| 05/25/2000 | WO2000029830A1 Refractometer and method for qualitative and quantitative measurements |
| 05/25/2000 | WO2000029829A1 Simultaneous determination of equilibrium and kinetic properties |
| 05/25/2000 | WO2000029828A1 In-stack direct particulate mass measurement apparatus and method with pressure/flow compensation |
| 05/25/2000 | WO2000029817A1 Self-diagnostic system for conditioned maintenance of machines operating under intermittent load |
| 05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029620A1 Methods of facilitating vascular growth |
| 05/25/2000 | WO2000029617A2 Water-soluble luminescent quantum dots and bioconjugates thereof |
| 05/25/2000 | WO2000029611A2 Novel primers and probes for detecting hiv |
| 05/25/2000 | WO2000029610A1 Analytical system based upon spore germination |
| 05/25/2000 | WO2000029609A1 N-terminally truncated her-2/neu protein as a cancer prognostic indicator |
| 05/25/2000 | WO2000029590A1 Method for identifying inhibitors of ipc synthase |
| 05/25/2000 | WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029580A1 Calcium binding protein |
| 05/25/2000 | WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 05/25/2000 | WO2000029574A2 Inflammation-associated genes |
| 05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
| 05/25/2000 | WO2000029565A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 05/25/2000 | WO2000029564A2 Human glycine transporter type 2 |
| 05/25/2000 | WO2000029556A2 Identification of glycosphingolipids that promote hiv-1 entry into cells |
| 05/25/2000 | WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 05/25/2000 | WO2000029442A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 05/25/2000 | WO2000029441A1 Novel g protein-coupled receptor protein, its dna and ligand thereof |
| 05/25/2000 | WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029434A2 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 05/25/2000 | WO2000029433A2 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines |
| 05/25/2000 | WO2000029432A1 Heliobacter pylori antigen |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029111A1 Device and methods for single step collection and assaying of biological fluids |
| 05/25/2000 | WO2000029020A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase |
| 05/25/2000 | WO2000029008A2 Hiv-specific t-cell induction |
| 05/25/2000 | WO2000028982A2 Increasing bone strength with selected bisphosphonates |
| 05/25/2000 | WO2000028972A2 Nanocapsules and method of production thereof |
| 05/25/2000 | WO2000028897A1 Body fat measurement system |
| 05/25/2000 | WO2000028813A1 Treatment of myelogenous leukemia |
| 05/25/2000 | WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 05/25/2000 | WO2000019196A3 Method and test kit for evaluating the oxidative modification of substances containing protein by measuring their antioxidative activity |
| 05/25/2000 | WO2000017658A3 Diagnosis of myocardial disease or stroke using factor ix activation peptide |
| 05/25/2000 | WO2000017653A3 Salmonella antigen formulation and kit for detecting salmonella antibodies |
| 05/25/2000 | WO2000017233A3 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 05/25/2000 | WO2000015788A3 Dna sequence encoding oncofetal ferritin protein |
| 05/25/2000 | WO2000015209A3 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 05/25/2000 | WO2000014276A3 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids |
| 05/25/2000 | WO2000014228A8 Neutral amino acid transporter and gene thereof |
| 05/25/2000 | WO2000009983A8 Device and method for non-invasively measuring and determining moisture content and density of loose and packaged tobacco |
| 05/25/2000 | WO2000008443A9 Multiple frequency fluorescence lifetime imaging |
| 05/25/2000 | WO2000007545A8 Apoptosis proteins |
| 05/25/2000 | WO2000001410A9 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 05/25/2000 | WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens |
| 05/25/2000 | WO1999061655A8 Transition state binding assay |
| 05/25/2000 | WO1999055849A8 Tyrosine phosphatase ia-2, gad and rotavirus vp7 immunity |
| 05/25/2000 | WO1999051762A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 05/25/2000 | DE19951618A1 Probengefäß zur Bestimmung der Abkühlkurve von geschmolzenem Metall Sample vessel to determine the cooling curve of molten metal |
| 05/25/2000 | DE19932146A1 Process for recording oxygen respiration of small animals in long-term tests comprises monitoring proportional signal changes in pressure and dissolved oxygen in a fluid |
| 05/25/2000 | DE19853428A1 Biosensor, used in surface plasmon resonance techniques, comprises surface layer of precious metal bound to a hydrogel, a surfactant or biotin layer via monolayer of organic molecules |
| 05/25/2000 | DE19852083A1 Verfahren zur quantitativen Bestimmung von Polyasparaginsäure A method for the quantitative determination of polyaspartic acid |
| 05/25/2000 | DE19850186A1 Neue Primer und Sonden zum Nachweis von HIV New primers and probes for the detection of HIV |
| 05/25/2000 | DE19840095A1 Quality testing of materials, used e.g. to detect contaminants in foods, pharmaceuticals or water, by ashing, extracting salt and examining its crystal pattern |
| 05/25/2000 | CA2351891A1 Analytical system based upon spore germination |
| 05/25/2000 | CA2351711A1 Nanocapsules and method of production thereof |
| 05/25/2000 | CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines |
| 05/25/2000 | CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | CA2351313A1 Immunoglobulin superfamily proteins |
| 05/25/2000 | CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | CA2350911A1 Hiv-specific t-cell induction |
| 05/25/2000 | CA2350789A1 Device and method for analyzing a biologic sample |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350698A1 Human glycine transporter type 2 |
| 05/25/2000 | CA2350622A1 Apparatus and method for measuring the characteristics of an oilfield fluid or the like |
| 05/25/2000 | CA2350415A1 Inflammation-associated genes |
| 05/25/2000 | CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | CA2350389A1 Calcium binding protein |
| 05/25/2000 | CA2350228A1 Novel g protein-coupled receptor protein, its dna and ligand thereof |
| 05/25/2000 | CA2350131A1 A method of detecting the presence of an analyte in a biological sample |
| 05/25/2000 | CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species |
| 05/25/2000 | CA2350078A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid |
| 05/25/2000 | CA2349618A1 Compositions and methods relating to the peroxisomal proliferator activated receptor-.alpha. mediated pathway |
| 05/25/2000 | CA2349581A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 05/25/2000 | CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | CA2346965A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 05/25/2000 | CA2340468A1 Methods of facilitating vascular growth |
| 05/24/2000 | EP1003120A1 Computerized method and apparatus for analyzing nucleic acid assay readings |
| 05/24/2000 | EP1003038A1 Immunoassay apparatus |
| 05/24/2000 | EP1003037A1 Analytical test device and method of use |
| 05/24/2000 | EP1003033A1 Sensor comprising an oligomer binding layer and method of making such sensor and arrays of such sensors |
| 05/24/2000 | EP1003032A1 Sensor comprising an oligomer binding layer and method of making such sensor and arrays of such sensors |
| 05/24/2000 | EP1002877A2 Gene amplifying method |
| 05/24/2000 | EP1002874A2 Redox reactions for analyte determination using tetrazolium compounds |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002567A1 Dissolution of gas |
| 05/24/2000 | EP1002297A1 A digital imaging system for assays in well plates, gels and blots |